Go ahead, call it a comeback. There’s new energy around connecting — whether among people or technologies — thanks to the not-so-distant pandemic lockdowns that reminded the world why relationships matter. This comes as Abbott’s partnerships with diabetes and digital health tech companies, from startups to established enterprises, are coming to life around the globe. These partnerships are leading the way for connected tech, expanding the FreeStyle Libre portfolio user base and creating seamless, personalized diabetes care that’s lessening the burden of round-the-clock diabetes management for the approximately 63 million people worldwide who need insulin to help manage their glucose levels.1 “There’s enormous potential for technologies like our FreeStyle Libre systems to simplify how people manage their diabetes,” said Jared Watkin, senior vice president of Abbott’s diabetes care business. “But continuous glucose monitors are only one piece of the diabetes care puzzle. That’s where the power of partnership comes in.” Here’s what you need to know about the partnerships connecting Abbott’s FreeStyle Libre platform with major insulin delivery systems and changing the future of diabetes care.